MT1 melatonin receptor in the human retina:: Expression and localization

被引:0
|
作者
Scher, J
Wankiewicz, E
Brown, GM
Fujieda, H
机构
[1] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada
[2] Clarke Inst Psychiat Div, Ctr Addict & Mental Hlth, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Melatonin's function in human vision is far from understood, in part because of the lack of information on its cellular targets. Therefore, expression and localization of the MT1 melatonin receptor in human retina was examined. METHODS. Postmortem nonpathologic human eyes from nine donors were investigated, three by reverse transcriptionpolymerase chain reaction (RT-PCR) for MT1 and MT2 transcripts and six by immunocytochemistry, using a peptide-specific anti-MT1 receptor antibody. RESULTS. RT-PCR suggested that both MT1 and MT2 transcripts had similar levels of expression. Vertical slices of human retina demonstrated MT1 immunoreactivity in cell bodies along the outer border of the inner nuclear layer (INL), along the inner border of the INL, in cell bodies within the ganglion cell layer (GCL), and in the inner segments (IS) of photoreceptors. Double immunolabeling using anti-MT1 and tyrosine hydroxylase revealed that 69% of CA1 and 63% of CA2 dopaminergic neurons exhibited MT1 immunoreaction. Double immunolabeling with anti-parvalbumin, a horizontal cell marker, showed that MT1-positive cells along the outer INL border were exclusively horizontal cells, and that 18% of horizontal cells in central retina expressed MT1. Double staining with MT1 and markers for both rod and cone photoreceptors suggest that IS staining is present on rod cells. CONCLUSIONS. The MT1 receptor is expressed in diverse neuronal cell types in the human retina, providing evidence of a significant role for melatonin and this receptor subtype in human vision.
引用
收藏
页码:889 / 897
页数:9
相关论文
共 50 条
  • [31] Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection
    Kaneko, Yuji
    Hayashi, Takuro
    Yu, SeongJin
    Tajiri, Naoki
    Bae, Eunkyung C.
    Solomita, Marianna A.
    Chheda, Sonia H.
    Weinbren, Nathan L.
    Parolini, Ornella
    Borlongan, Cesar V.
    [J]. JOURNAL OF PINEAL RESEARCH, 2011, 50 (03) : 272 - 280
  • [32] MT1 and MT2 melatonin receptor expression in mammalian vasculature and superior cervical ganglion
    Masana, MI
    Al-Ghoul, W
    Dubocovich, ML
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R72 - R72
  • [33] Endogenous and Exogenous Melatonin Exposure Attenuates Hepatic MT1 Melatonin Receptor Protein Expression in Rat
    Mathes, Alexander M.
    Heymann, Paul
    Ruf, Christian
    Huhn, Ragnar
    Hinkelbein, Jochen
    Volk, Thomas
    Fink, Tobias
    [J]. ANTIOXIDANTS, 2019, 8 (09)
  • [34] Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line
    Watanabe, Mari
    Kobayashi, Yoichi
    Takahashi, Noriyuki
    Kiguchi, Kazushige
    Ishizuka, Bunpei
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2008, 34 (04) : 567 - 573
  • [35] The Expression of MT1 Melatonin Receptor and Ki-67 Antigen in Melanoma Malignum
    Danielczyk, Karolina
    Dziegiel, Piotr
    [J]. ANTICANCER RESEARCH, 2009, 29 (10) : 3887 - 3895
  • [36] The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system
    Uz, T
    Arslan, AD
    Kurtuncu, M
    Imbesi, M
    Akhlsaroglu, M
    Dwivedi, Y
    Pandey, GN
    Manev, H
    [J]. MOLECULAR BRAIN RESEARCH, 2005, 136 (1-2): : 45 - 53
  • [37] Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives
    Comai, Stefano
    Lopez-Canul, Martha
    De Gregorio, Danilo
    Posner, Ada
    Ettaoussi, Mohamed
    Guarnieri, Fabrizia Claudia
    Gobbi, Gabriella
    [J]. PHARMACOLOGICAL RESEARCH, 2019, 144 : 343 - 356
  • [38] Neuropsychopharmacological properties of novel melatonin MT1 receptor ligands
    Comai, S.
    Posa, L.
    Ochoa-Sanchez, R.
    Spadoni, G.
    Gobbi, G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S569 - S569
  • [39] Publisher Correction: Structural basis of ligand recognition at the human MT1 melatonin receptor
    Benjamin Stauch
    Linda C. Johansson
    John D. McCorvy
    Nilkanth Patel
    Gye Won Han
    Xi-Ping Huang
    Cornelius Gati
    Alexander Batyuk
    Samuel T. Slocum
    Andrii Ishchenko
    Wolfgang Brehm
    Thomas A. White
    Nairie Michaelian
    Caleb Madsen
    Lan Zhu
    Thomas D. Grant
    Jessica M. Grandner
    Anna Shiriaeva
    Reid H. J. Olsen
    Alexandra R. Tribo
    Saïd Yous
    Raymond C. Stevens
    Uwe Weierstall
    Vsevolod Katritch
    Bryan L. Roth
    Wei Liu
    Vadim Cherezov
    [J]. Nature, 2019, 569 : E6 - E6
  • [40] Dopaminergic and GABAergic amacrine cells are direct targets of melatonin:: Immunocytochemical study of mt1 melatonin receptor in guinea pig retina
    Fujieda, H
    Scher, J
    Hamadanizadeh, SA
    Wankiewicz, E
    Pang, SF
    Brown, GM
    [J]. VISUAL NEUROSCIENCE, 2000, 17 (01) : 63 - 70